Skip to content

Clinical study of transcriptome-based diagnostic biomarker for acute febrile illness

Transcriptome-based diagnostic biomarker for acute febrile illness: a cross-sectional observational study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048605
Enrollment
Unknown
Registered
2021-07-11
Start date
2021-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute febrile illness

Interventions

Gold Standard:Etiological evidence (culture, PCR, etc.) and confirmed by both clinical specialists
Index test:Measured expression of host gene transcripts by qRT-PCR

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Body temperature > 38 degree C; 2. The course of the disease is less than or equal to 14 days; 3. Subjects fully informed and agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Basic diseases that affect immune function, such as advanced tumors, autoimmune diseases, immunodeficiency patients, and immunosuppressive patients; 2. Pregnancy; 3. There are mixed infections (viral combined bacterial infection, autoimmune disease combined with bacterial infection); 4. Inability to provide complete clinical data; 5. Any situation in which the clinician believes that the patient should not participate in this study for safety reasons or the interests of the patient.

Design outcomes

Primary

MeasureTime frame
Accuracy;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactWang Gang

Qilu Hospital of Shandong University

wangg1975@hotmail.com+86 18560082130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026